Physician profile
Danielle D Hilton
NPI 1225653462
$2,629.84
in general payments reported to CMS, 2019-2025
24 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.34 · 2022: $784 · 2023: $833 · 2024: $525 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,816.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $335.40 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $333.36 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Optinose US, INC. | $267.52 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $259.49 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $187.66 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $161.71 | 2022-2025 | |
| Pfizer INC. | $161.53 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $117.30 | 2022-2025 | |
| Abbott Laboratories | $95.63 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $88.77 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $88.66 | 2022-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.85 | 2022-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.46 | 2022-2024 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $49.59 | 2022-2025 | Capvaxive, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $47.35 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $46.76 | 2022-2023 | |
| Amgen INC. | $45.53 | 2022-2023 | Otezla, Repatha |
| Edwards Lifesciences Corporation | $45.16 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biohaven Pharmaceutical Holding Company LTD. | $41.65 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.48 | 2021-2023 | Trintellix |
| Daiichi Sankyo INC. | $27.58 | 2025 | Injectafer |
| Inari Medical, INC. | $20.89 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alexion Pharmaceuticals, INC. | $17.81 | 2022 | |
| Currax Pharmaceuticals LLC | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Hilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.